WASHINGTON, March 18 – Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Monday issued the following statement after AstraZeneca announced that it would cap out-of-pocket costs at $35 per month for its asthma and COPD inhalers, starting on June 1, 2024.
The announcement comes on the...